Eating disorders may develop from a variety of problems, not only genetic, but also environmental and psychological. Eating disorders can affect almost any age and gender, but the likelihood of developing eating disorders increases with a young age at first onset and in females.
At the end of a program of treatment, participants report improvements in several areas of their quality-of-life, with improvements in their bodies, social relationships, emotional wellbeing, and work performance.
Eating disorders are a broad range of abnormal eating behaviors and problems in which the individual will overeat in a misguided attempt to satisfy external eating and weight control concerns. Some subcategories are bulimia nervosa, binge eating disorder, and anorexia. Clinicians must be aware that the condition has been defined and identified across cultures and in a number of languages. There is a need for a coherent definition and research of the disorder.
Many treatments are used to treat eating disorders and most interventions are psychological and behavioral. There are three categories of psychiatric and supportive disorders: impulse control disorders, mood disorders, and anorexia nervosa-like disorders. No general diagnostic approach or general treatment style is universally appropriate for all eating disorders. More research is needed in better defining these groups and to determine the most appropriate treatment strategy.
Signs of eating disorders include lethargy, lack of hunger, overeating, weight loss, exercise or weight gain, fasting or starvation, and lack of physical activity. Other signs may include binge eating and vomiting. Symptoms of eating disorders may also include feeling tired and unwell, excessive hair growth, depression or anxiety, poor concentration, and poor impulse control. There are many different types of eating disorder, which have distinct causes and treatments. Eating disorders are a global problem, affecting males as well as females. There is a greater risk of developing an eating disorder in those with a learning disability or poor communication skills, and those who come from a background of mental illness.
Eating disorders like anorexia nervosa, bulimia, and binge eating disorder are not curable. Therefore, it is important to recognize them as early on as possible. The best way to get there is through a professional, professional-led, and supervised support team.
There are approximately 1.5 million Americans with eating disorders a year, a 2-tier rate of 1.6% of the U.S. population. These data have an important impact on estimates of total morbidity attributable to eating disorders; the actual rate of morbidity due to EDs may be twice as higher in the United States as estimates show.
There are different ways to describe what is new and what is outdated, but what is new or obsolete can be useful. The latest research on eating disorders is usually a result of two major phenomena, those eating disorder researchers are concerned with studying, and those eating disorder research researchers want to study. The desire to explore eating disorder and disordered eating, coupled with the desire to help those with eating disorders, has led to increased interest in this research topic by more than one researcher for many years. With all the recent, newly discovered, and still being discovered clues to the understanding of these disorders, it is important for all researchers to keep pace with what is being learned.
Eating disorders affect women in all populations. This article highlights the seriousness of disordered eating attitudes and behaviors and its potential impact on medical and psychological symptomatology, as well as the public health and political implications.
There is a great deal more to treatment than medication, and treatments work at a variety of levels: cognitive behavior therapy, medication, support groups. By partnering in health and wellness, medical providers and health departments can help improve the outcome of treatment for eating disorders.
The SF-36 and the EDSS are useful quality-of-life assessments for patients with ED. There was no change in physical HRQOL after treatment. However, there was a trend toward improvement in general mental HRQOL after treatment.
A study of 476 patients concluded that there was no clear justification for restricting the number of drugs or the total dose. A number of studies also reported that patients were able to adjust themselves to the drugs and dose adjustments were not indicated. Further research in the area is warranted to draw definite conclusions. Treatment was rated 'B'-grade' for severity by the study authors. Treatment-related side effects were reported in 19% of patients, with nausea and vomiting being the most prevalent. A similar survey of patients in the US reports that 16% have nausea and 15% have vomiting associated with treatment by doctors, and 15% for doctors' assistants. The most prevalent side effect was diarrhea.